• Development of DruMAP, Drug Metabolism and pharmacokinetics Analysis Platform
• Development of in silico prediction models to evaluate pharmacokinetic profiles using chemical structure information

More information is available at the following links.

• P5-06 (Development of a pharmacokinetics prediction system using multiscale integrated modeling: 13. Development of DruMAP, Drug Metabolism and pharmacokinetics Analysis Platform)
• P5-07 (Development of a pharmacokinetics prediction system using multiscale integrated modeling: 14. In silico three-class predictor of human intestinal absorption with Caco-2 permeability and dried-DMSO solubility)
• P5-08 (Development of a pharmacokinetics prediction system using multiscale integrated modeling:15. Development of an in silico prediction system of human renal excretion and clearance from chemical structure information)
• P6-09 (Computational drug target prediction using PU learning approach)

More information is available at the following links.

We are going to present poster presentation.

• F-13: Prediction of pharmacokinetic profiles using chemical structure information: Fraction unbound in plasma and renal excretion
• F-15: Development of DruMAP, Drug Metabolism and pharmacokinetics Analysis Platform
• L-43: A study of gut microbial variations associated with phenotypic metadata in a healthy Japanese population
• V-123: Pentachlorophenol affects RIG-1 antiviral pathway that produces type I interferon at the transcriptional level

More information is available at the following links.